BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 13457604)

  • 1. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration.
    UZMAN LL
    AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease.
    OKINAKA S; YOSHIKAWA M; TOYODA M; MOZAI T; TOYOKURA Y; KAMEYAMA M
    AMA Arch Neurol Psychiatry; 1954 Nov; 72(5):573-8. PubMed ID: 13206477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease).
    UZMAN LL; IBER FL; CHALMERS TC
    Am J Med Sci; 1956 May; 231(5):511-8. PubMed ID: 13313537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis].
    Pawlak J
    Wiad Lek; 1975 Jun; 28(12):1041-4. PubMed ID: 1136474
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
    Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 9. [Copper metabolism: ultimate therapeutic implications in cholestasis].
    Thierman-Duffaud D; Lévy VG
    Med Chir Dig; 1981; 10(4):331-2. PubMed ID: 7300488
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic copper metabolism: insights from genetic disease.
    Tao TY; Gitlin JD
    Hepatology; 2003 Jun; 37(6):1241-7. PubMed ID: 12773998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.
    Osborn SB; Walshe JM
    Clin Sci; 1965 Dec; 29(3):575-81. PubMed ID: 5848709
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues.
    Dekaban AS; O'Reilly S; Aamodt R; Rumble WF
    Trans Am Neurol Assoc; 1974; 99():106-9. PubMed ID: 4219083
    [No Abstract]   [Full Text] [Related]  

  • 14. Copper dynamics in Wilson's disease.
    Osborn SB; Walshe JM; Williams R
    Ann Biol Clin (Paris); 1972; 30(4):391-6. PubMed ID: 5082973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissociative action of copper on the polysomes in the rat liver and brain. A possible pathogenic mechanism of Wilson's disease].
    Hernández-Pérez O; Ballesteros LM; Méndez D; Rosado A
    Gac Med Mex; 1975 Sep; 110(3):205-11. PubMed ID: 1205062
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on copper metabolism. XIII. Hepatolenticular degeneration.
    CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; WINTROBE MM; BEAN WB
    J Clin Invest; 1954 Nov; 33(11):1487-501. PubMed ID: 13211803
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver copper levels in intrahepatic cholestasis of childhood.
    Evans J; Newman S; Sherlock S
    Gastroenterology; 1978 Nov; 75(5):875-8. PubMed ID: 700330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 19. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
    Stapelbroek JM; Ploos van Amstel JK; van Hattum J; van den Berg LH; Klomp LW; Houwen RH
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):603-5. PubMed ID: 12701394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical demonstration of copper in a case of hepatolenticular degeneration.
    GREEN CL
    Am J Pathol; 1955; 31(3):545-53. PubMed ID: 14376512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.